Automated Multiplex CRISPR-Cas14a (Cas12f2) Vector Foundry Cap Rate 2026

Underwrite GMP Class A/B continuous synthetic ultra-compact Cas14a/Cas12f2 (sub-450aa) non-viral synthetic lipid nanoparticle (LNP) packaging cleanroom suites, $615/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

Cas14a Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP Cas14a Foundry Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation